Oral Medication For Leber's Congenital Amaurosis Demonstrates Biological Signal In Early Study

Thursday, April 22, 2010

Comments

Ocular Surgery News

Three patients enrolled in a phase 1b proof of concept study for an oral medication therapy for Leber's congenital amaurosis had vision gains and reported improvements in functional vision after 7 days of treatment.

Full Story

The following is a photograph after fluorescein staining of a 40 year old patient with complaints of gritty sensation OU for the past several months. All of the following might be expected except:
1. increased tear break-up time
2. decreased tear meniscus
3. 5mm Schirmer test
4. filamentary keratitis
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Oral Medication For Leber's Congenital Amaurosis Demonstrates Biological Signal In Early Study

Comments

Quick Quiz

The following is a photograph after fluorescein staining of a 40 year old patient with complaints of gritty sensation OU for the past several months. All of the following might be expected except:

AdGlare RMR Ad

Featured Products

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse

SPECTRALIS Diagnostic Imaging Platform

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us